The allotment for Sudeep Pharma's Rs 895 crore IPO is scheduled for finalization today after an overwhelming subscription of nearly 100 times. Strong demand from institutional investors (QIBs 213x, NIIs 116x) and a Grey Market Premium (GMP) of Rs 87 suggest a potential listing price of Rs 680, an estimated 14.67% gain. Investors can check their status via BSE/NSE.